Initial experience with a new laparoscopic ultrasound probe for guided biopsy in the staging of upper gastrointestinal cancer
Research output: Contribution to journal › Journal article › Research › peer-review
BACKGROUND: Until recently, laparoscopic ultrasound (LUS)-guided biopsy has been difficult with the available probes on the market. This study aimed to present a new laparoscopic ultrasound probe (Hitachi, EUP-OL531) for guided biopsy and describe its impact on the clinical outcome for patients with upper gastrointestinal (UGI) cancer. METHODS: Patients referred with confirmed UGI cancer from June 2003 to December 2006 were included in the study. After a standard workup including computed tomography, endoscopic ultrasound, and ultrasound of the neck, operable patients underwent LUS with or without fine-needle aspiration (FNA). RESULTS: From a total of 175 patients, 19 (11%) underwent LUS-guided FNA after a significant lesion was found. The LUS-guided FNA confirmed distant metastasis in 14 of the 19 patients and changed the clinical management for these 14 patients (8%). There were no adverse events due to LUS or LUS-guided FNA. CONCLUSION: The current results with the new LUS probe for guided FNA are encouraging in terms of its diagnostic ability, safety, and ease of use.
Original language | English |
---|---|
Journal | Surgical Endoscopy |
Volume | 23 |
Issue number | 7 |
Pages (from-to) | 1552-8 |
Number of pages | 7 |
ISSN | 0930-2794 |
DOIs | |
Publication status | Published - 2009 |
Bibliographical note
Keywords: Aged; Antineoplastic Agents; Biopsy, Fine-Needle; Carcinoma; Combined Modality Therapy; Equipment Design; Esophageal Neoplasms; Esophageal Stenosis; Esophagogastric Junction; Female; Humans; Laparoscopy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Needles; Neoplasm Invasiveness; Neoplasm Staging; Palliative Care; Pilot Projects; Prospective Studies; Stents; Stomach Neoplasms; Ultrasonography, Interventional
ID: 20341750